Cancer Letters 2000-11-10

Anti-transforming nature of ascorbic acid and its derivatives examined by two-stage cell transformation using BALB/c 3T3 cells.

T Tsuchiya, E Kato-Masatsuji, T Tsuzuki, M Umeda

Index: Cancer Lett. 160(1) , 51-8, (2000)

Full Text: HTML

Abstract

The anti-transforming effects of sodium ascorbate and its stable derivatives were examined in the two-stage transformation assay. When BALB/c 3T3 cells were treated with 0.2 microg/ml 20-methylcholanthrene as an initiator, and 100 ng/ml 12-O-tetradecanoylphorbol-13-acetate as a promoter, the addition at the promotion stage of L-ascorbic acid-2-phosphate ester magnesium (APM) was most marked in the inhibition of transformation. The inhibitory effects of sodium ascorbate and ascorbic acid-2-glucoside (AG) were comparable, but weaker than those of APM; L (+)-ascorbic acid-2-sulfate ester disodium 2H(2)O showed little effect. When phorbol 12, 13-didecanoate or tumor necrosis factor alpha (TNF-alpha) were used as promoters, APM also effectively suppressed transformation.


Related Compounds

Related Articles:

Identification of sulfation sites of metabolites and prediction of the compounds' biological effects.

2006-10-01

[Anal. Bioanal. Chem 386(3) , 666-74, (2006)]

L-ascorbyl-2-sulfate alleviates Atlantic salmon scurvy.

1994-09-01

[Proc. Soc. Exp. Biol. Med. 206(4) , 421-4, (1994)]

Quantitative analysis of ascorbic acid-2-sulfate by high-performance liquid chromatography with electrochemical detection.

[J. Chromatogr. A. 308 , 306-9, (1984)]

Specific determination of arylsulfatase A activity.

1986-01-15

[Experientia 42(1) , 33-5, (1986)]

Isolation and characterization of rat hepatic ascorbic acid-2-sulfatases.

1987-01-01

[Enzyme 37(3) , 134-40, (1987)]

More Articles...